Centers for Disease Control and Prevention,update

 

New Research to Better Communicate Antimicrobial Resistance, Toolkit Now Available Online

CDC-Funded Study Provides National Burden of Sepsis in Children

Data Update: CDC-Funded Study Provides National Burden of Sepsis in Children

A new CDC-funded study published in the Journal of the American Medical Association (JAMA) shows the impact of pediatric sepsis in U.S. hospitals. Using a robust, validated Pediatric Sepsis Event definition based on electronic health record data, the authors estimate that:

Centers for Disease Control and Prevention:McKnight Heroes Prize Nominations Now Open

 

Award recognizes individuals dedicated to protecting patients from healthcare outbreaks

Early identification and timely response to a healthcare outbreak is critical to minimizing the number of people negatively impacted.  Together, the Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created The McKnight Prize for Healthcare Outbreak Heroes to encourage and reward those who serve and protect patients from harm related to healthcare outbreaks. Nominations for this year’s prize are now being accepted.  Candidates for the McKnight Heroes Prize can be

Centers for Disease Control and Prevention:update

 

2024 National and State Healthcare-Associated Infections (HAI) Progress Report Shows Improvements in Preventing HAIs

CDC has released the 2024 National and State Healthcare-Associated Infections (HAI) Progress Report, which shows progress in preventing several important HAIs in acute care hospitals (ACHs) compared to 2023. This HAI Progress Report continues to show decreases in HAIs that align more closely with progress made prior to the start of the COVID-19 pandemic in 2020.  Decreases in national standardized infection ratio (SIR)* from 2023 to 2024 for some HAIs in ACHs included:

Centers for Disease Control and Prevention:The 2023 PLACES Data Are Now Live!

 

December 5, 2025

The 2023 PLACES Data are now live!

The Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion is excited to announce the release of 2023 PLACES data.

How PLACES Can Improve Your Health Efforts

The PLACES data tool provides local, model-based estimates for understanding health outcomes, preventive service use, health-risk behaviors, disabilities, health status, and health-related social needs at the local level. PLACES covers various geographic areas, including counties, census-designated places, census tracts, and ZIP Code Tabulation Areas.

CDC: Increases in NDM-CRE in the United States

 

New CDC Report Warns of Increases in NDM-CRE, Urges Healthcare Provider Awareness and Testing

Through CDC’s Antimicrobial Resistance Laboratory Network, CDC experts have detected a substantial rise in carbapenem-resistant Enterobacterales (CRE) producing the New Delhi metallo-β-lactamase (NDM) carbapenemase. This increase in NDM-CRE has also been observed in complementary CDC surveillance platforms.

Centers for Disease Control and Prevention CDC,update

Restoring the Gut Microbiome with Fecal Microbiota Transplants

Antibiotics are lifesaving tools but can come with risks. Antibiotics can kill everything in a patient’s gut microbiome—including helpful and harmful microbes. This can lead to germs taking over the gut microbiome, and it can take a long time for the microbiome to return to normal after antibiotic treatment. In some cases, the gut microbiome may never restore on its own, and fecal microbiota can be used to replenish and help protect against germs.  Guest blogger, Colleen Kraft, MD, shares her work with finding ways to restore the gut microbiome with fecal microbiota transplants.   Read on to find out more about her work with the microbiome and why it matters in efforts to combat antimicrobial resistance.

Colleen S. Kraft, MD

	Have you read CDC’s newest blog post on exploring the microbiome as a way to combat antimicrobial resistance? Read the Safe Healthcare Blog here: https://blogs.cdc.gov/safehealthcare/exploring-the-microbiome-to-combat-AR

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348

Centers for Disease Control and Prevention:Working Together to Achieve the Targets...

 

Centers for Disease Control and Prevention  Working Together to Achieve the Targets of the 2024 High-level Meeting on Antimicrobial Resistance Political Declaration Join us Thursday, December 12, 2024, at 11 a.m. EST for CDC’s next AMR Exchange, It’s Time for Action: Working Together to Achieve the Targets of the 2024 UNGA High-level Meeting on AMR Political Declaration. Antimicrobial resistance is an urgent global public health threat, killing more than 1 million people worldwide each year. In late September, global leaders met in New York City for the second United Nations General Assembly (UNGA) High-level Meeting (HLM) on Antimicrobial Resistance (AMR). The political declaration from the HLM identifies specific commitments and targets for all countries and AMR stakeholders. Join us to hear from CDC and a panel of experts to learn more about actionable commitments and targets from the UNGA HLM political declaration, what governmental and non-governmental partners are doing to turn political commitment into public health action, and approaches to strengthen One Health collaboration across the globe. Taking part in the conversation are experts whose work in the United States and around the world is helping transform how we combat antimicrobial resistance threats. Don’t forget to follow us on X (formerly Twitter) @CDC_AR. You can watch previous AMR Exchange webinars if you missed any. I just registered for @CDC_AR’s AMR Exchange webinar on Dec. 12 discussing collaborative actions to address the @UN political declaration on #AntimicrobialResistance. Register to join: https://bit.ly/3OdfY8r   Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348

 

CDC and Global Partners Commit to Collective Action to Combat Antimicrobial Resistance

In late September 2024, global leaders gathered in New York City for the second United Nations General Assembly High-level Meeting (UNGA HLM) on Antimicrobial Resistance. Since the first UNGA HLM on Antimicrobial Resistance in 2016, the United States (U.S.) has made tremendous progress toward the goals in the U.S. National Action Plan for Combating Antibiotic-resistant Bacteria. This progress—which could not have been made without dedicated efforts from the U.S. Government and our partners working across One Health—demonstrates what is possible with collective effort toward shared goals and targets. The UNGA HLM provided a platform for CDC and global partners to continue to identify and commit to actions needed to combat antimicrobial resistance. CDC took the opportunity afforded by the UNGA HLM and surrounding events to share the impact of our investments in: Building laboratory and surveillance capacity Strengthening infection prevention capacity Improving appropriate antibiotic and antifungal use Increasing antimicrobial resistance awareness and knowledge Advancing innovation and research The UNGA HLM was also an opportunity to create new connections and strengthen established partnerships with governmental and non-governmental partners across the globe.

Centers for Disease Control and Prevention,update

World Sepsis Day: Protect Children from Sepsis

Today is World Sepsis Day. Anyone can get an infection, and almost any infection can lead to sepsis. Most sepsis cases in children and young adults start before they go to the hospital. This year, CDC has expanded its suite of educational materials with two new toolkits for parents, caregivers of children, youth organizations, and schools. In the latest Safe Healthcare Blog, find out how you can use this lifesaving information to learn what sepsis is, the signs and symptoms, and how to act fast, so you can protect children from sepsis.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348